TGF-β1-triggered BMI1 and SMAD2 cooperatively regulate miR-191 to modulate bone formation

Area of Science:

• Biochemistry
• Cell Biology
• Regenerative Medicine

Background:

• Transforming growth factor β 1 (TGF-β1) is crucial for bone homeostasis, but its signaling in bone formation is not fully understood.
• MicroRNAs (miRNAs) play regulatory roles in cellular processes, including osteogenesis.

Purpose of the Study:

• To elucidate the role of microRNA-191 (miR-191) in TGF-β1-mediated bone formation and regeneration.
• To investigate the molecular mechanisms underlying miR-191 regulation by TGF-β1 signaling.

Main Methods:

• Quantification of miR-191 levels during osteogenesis in bone marrow mesenchymal stem cells (BMSCs).
• Analysis of miR-191 expression in bone tissues from different age groups.
• In vivo studies using hydrogels with miR-191-low BMSCs for bone repair assessment.
• Mechanistic studies involving transcription factors BMI1 and SMAD2 and their interaction with the miR-191 promoter.

Main Results:

• miR-191 was downregulated during osteogenesis and further reduced by TGF-β1 in BMSCs.
• Lower miR-191 levels were observed in children's bone tissue compared to middle-aged individuals and negatively correlated with collagen type I alpha 1 chain (COL1A1).
• Depletion of miR-191 significantly enhanced osteogenesis and bone formation in vivo, with hydrogels of miR-191-low BMSCs showing potent bone repair.
• TGF-β1 upregulated BMI1 and pSMAD2; SMAD2 activated miR-191 transcription, while BMI1 competed with SMAD2 for the promoter region, reducing miR-191 levels.

Conclusions:

• TGF-β1-induced BMI1 and SMAD2 negatively regulate miR-191, which in turn modulates bone formation and regeneration.
• Inhibition of miR-191 presents a potential therapeutic strategy for enhancing bone repair in clinical settings.